Back to Search
Start Over
Phase Ib dose-escalation study of the selective, non-covalent, reversible Bruton’s tyrosine kinase inhibitor vecabrutinib in B-cell malignancies
- Source :
- Haematologica, Vol 107, Iss 4 (2021)
- Publication Year :
- 2021
- Publisher :
- Ferrata Storti Foundation, 2021.
- Subjects :
- Diseases of the blood and blood-forming organs
RC633-647.5
Subjects
Details
- Language :
- English
- ISSN :
- 03906078 and 15928721
- Volume :
- 107
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Haematologica
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.2b83f0254400461d8896d202887eadb7
- Document Type :
- article
- Full Text :
- https://doi.org/10.3324/haematol.2021.280061